Strumento inattivo

Altre lingue Silence Therapeutics plc London S.E.

Azioni

SLN

GB00B9GTXM62

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference	30/04
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors	29/04
Silence Therapeutics plc Announces Retirement of Alistair Gray from Board of Directors, Effective May 1, 2024	29/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19/04
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	16/04
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	15/04
Silence Therapeutics : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION - Form 6-K	15/04
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	12/04
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)	08/04
Silence Therapeutics plc Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)	08/04
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27/03
European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading	18/03
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading	15/03
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	14/03
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13/03
Silence Therapeutics Says Phase 2 Study of High Lipoprotein(a) Treatment Meets Primary Endpoint	13/03
Sector Update: Health Care Stocks Gain Premarket Wednesday	13/03
Silence Therapeutics' 2023 Loss Narrows, Revenue Rises	13/03
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights	13/03
Silence Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	13/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Silence Therapeutics plc London S.E.

Azioni

SLN

GB00B9GTXM62

Altre lingue

Filtri